Malaria severity: Possible influence of the E670G PCSK9 polymorphism: A preliminary case-control study in Malian children
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Malaria severity: Possible influence of the E670G PCSK9 polymorphism: A preliminary case-control study in Malian children
Authors
Keywords
Malaria, Alleles, Cholesterol, Variant genotypes, Molecular genetics, Hypercholesterolemia, Blood plasma, Child health
Journal
PLoS One
Volume 13, Issue 2, Pages e0192850
Publisher
Public Library of Science (PLoS)
Online
2018-02-16
DOI
10.1371/journal.pone.0192850
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The membrane as the gatekeeper of infection: Cholesterol in host–pathogen interaction
- (2016) G. Aditya Kumar et al. CHEMISTRY AND PHYSICS OF LIPIDS
- JCL roundtable: PCSK9 inhibitors in clinical practice
- (2016) W. Virgil Brown et al. Journal of Clinical Lipidology
- Differential Expression of PCSK9 Modulates Infection, Inflammation, and Coagulation in a Murine Model of Sepsis
- (2016) Dhruva J. Dwivedi et al. SHOCK
- Cytokine response during non-cerebral and cerebral malaria: evidence of a failure to control inflammation as a cause of death in African adults
- (2016) Yakhya Dieye et al. PeerJ
- Both Rare and Common Variants inPCSK9Influence Plasma Low-Density Lipoprotein Cholesterol Level in American Indians
- (2015) Ching-Wei Tsai et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- The associations between proprotein convertase subtilisin/kexin type 9 E670G polymorphism and the risk of coronary artery disease and serum lipid levels: a meta-analysis
- (2015) Gaojun Cai et al. Lipids in Health and Disease
- Reducing LDL with PCSK9 Inhibitors — The Clinical Benefit of Lipid Drugs
- (2015) Brendan M. Everett et al. NEW ENGLAND JOURNAL OF MEDICINE
- Interaction of pathogens with host cholesterol metabolism
- (2014) Dmitri Sviridov et al. CURRENT OPINION IN LIPIDOLOGY
- Influence of PCSK9 polymorphisms on plasma lipids and response to atorvastatin treatment in Brazilian subjects
- (2014) Jacqueline M. Anderson et al. Journal of Clinical Lipidology
- PCSK9 is a critical regulator of the innate immune response and septic shock outcome
- (2014) K. R. Walley et al. Science Translational Medicine
- Differential effects of PCSK9 loss of function variants on serum lipid and PCSK9 levels in Caucasian and African Canadian populations
- (2013) Janice Mayne et al. Lipids in Health and Disease
- Improvement of the efficacy of dihydroartemisinin with atorvastatin in an experimental cerebral malaria murine model
- (2013) Jérôme Dormoi et al. MALARIA JOURNAL
- Serum lipids and lipoproteins in malaria - a systematic review and meta-analysis
- (2013) Benjamin J Visser et al. MALARIA JOURNAL
- Proprotein Convertases Subtilisin/Kexin Type 9, an enzyme turned escort protein: Hepatic and extra hepatic functions (第9型前蛋白转换酶-枯草溶菌素/蛋白酶K,一种酶转变的护送蛋白:在肝脏与肝外的功能)
- (2013) Majambu Mbikay et al. Journal of Diabetes
- The M2 Module of the Cys-His-rich Domain (CHRD) of PCSK9 Protein Is Needed for the Extracellular Low-density Lipoprotein Receptor (LDLR) Degradation Pathway
- (2012) Yascara Grisel Luna Saavedra et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Atorvastatin treatment is effective when used in combination with mefloquine in an experimental cerebral malaria murine model
- (2012) Jean-Baptiste Souraud et al. MALARIA JOURNAL
- Novel Loss-of-Function PCSK9 Variant Is Associated with Low Plasma LDL Cholesterol in a French-Canadian Family and with Impaired Processing and Secretion in Cell Culture
- (2011) J. Mayne et al. CLINICAL CHEMISTRY
- Plasmodium salvages cholesterol internalized by LDL and synthesized de novo in the liver
- (2010) Mehdi Labaied et al. CELLULAR MICROBIOLOGY
- The LDL Receptor
- (2009) Joseph L. Goldstein et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Plasma PCSK9 Is Associated with Age, Sex, and Multiple Metabolic Markers in a Population-Based Sample of Children and Adolescents
- (2009) A. Baass et al. CLINICAL CHEMISTRY
- Mutations and polymorphisms in the proprotein convertase subtilisin kexin 9 (PCSK9) gene in cholesterol metabolism and disease
- (2009) Marianne Abifadel et al. HUMAN MUTATION
- Blood Coagulation, Inflammation, and Malaria
- (2008) Ivo M. B. Francischetti et al. MICROCIRCULATION
- Molecular population genetics of PCSK9: a signature of recent positive selection
- (2008) Keyue Ding et al. Pharmacogenetics and Genomics
- Genetic variants in PCSK9 in the Japanese population: Rare genetic variants in PCSK9 might collectively contribute to plasma LDL cholesterol levels in the general population
- (2007) Yasuko Miyake et al. ATHEROSCLEROSIS
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started